An M8 Greyhound of the 16th Armored Division rolls through the main square in Pilsen, Czech Republic during the liberation on ...
President Volodymyr Zelenskyy has said that Ukraine does not yet have the strength to liberate occupied Crimea and part of ...
Vivani Medical began the LIBERATE-1 trial, testing a six-month exenatide implant for chronic weight management in Australia. The study uses NanoPortal technology, with results expected in mid-2025 and ...
名为LIBERATE-1的试验正在澳大利亚进行,标志着Vivani专有NanoPortal™药物植入技术的首次应用。该试验旨在评估exenatide植入剂在超重或肥胖参与者中的安全性、耐受性和药代动力学特征,以体重变化作为主要衡量指标。